PF-4455242
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
2-Methyl-N-{[2’-(1-pyrrolidinylsulfonyl)-4-biphenylyl]methyl}-1-propanamine
|
|
Clinical data | |
Routes of administration |
Oral |
Identifiers | |
CAS Number | 1202647-54-8 |
ATC code | None |
PubChem | CID: 44599828 |
ChemSpider | 26610764 |
Chemical data | |
Formula | C21H28N2O2S |
Molecular mass | 372.524 g/mol |
|
|
|
PF-4455242 is a selective, short-acting (non-"inactivating") antagonist of the κ-opioid receptor.[1][2] Discovered by Pfizer in 2009, it was pursued in a phase I clinical trial for the treatment of bipolar disorder,[3] and was also investigated as a treatment for depression and substance abuse.[4] However, development was stopped in September 2010 due to toxicology findings in animals that had been exposed to the drug for three months.[3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Amines
- Kappa antagonists
- Pyrrolidines
- Sulfones
- Nervous system drug stubs